Feedback / Questions
etrolizumab (RG7413) - Roche
Etrolizumab: NME submission in US for ulcerative colitis in 2020
(Roche)
-
Jul 26, 2019 -
H1 2019 results: Regulatory submission in EU for ulcerative colitis in 2020
BLA • European regulatory
https://www.roche.com/dam/jcr:bf0aee4a-439c-4656-a3b9-d61e5752dde2/en/irp190725.pdf
Jul 26, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious